查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750790

美國生物樣本庫市場規模、佔有率、趨勢分析報告：按產品/服務、生物檢體、類型、應用、地區、細分預測，2025-2030 年

U.S. Biobanks Market Size, Share & Trends Analysis Report By Product & Service, By Biospecimen (Human Tissues, Organs, Stem Cells), By Type (Physical/Real Biobanks, Virtual Biobanks), By Application, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國生物庫市場的成長與趨勢：

根據 Grand View Research, Inc. 的新報告，美國生物庫市場規模預計到 2030 年將達到 244.8 億美元，2025 年至 2030 年的複合年成長率為 6.26%。

這一成長源於藥物開發、個人化醫療和臨床研究對高品質生物檢體的需求不斷成長。生物銀行技術的進步、製藥和生物技術公司投資的增加以及基因組學和再生醫學應用的不斷擴展，進一步推動了市場擴張。

精準醫療日益受到重視，極大地推動了美國醫療保健和研究機構對高品質、帶註釋的生物檢體的需求。這些樣本對於支持生物標記發現、患者分層和標靶治療開發等關鍵活動至關重要。生物樣本庫在此過程中發揮關鍵作用，它提供可靠的途徑來獲取多樣化、臨床相關的生物檢體，這些樣本對於轉化研究和藥物開發至關重要。隨著製藥公司、研究機構和診斷公司優先考慮個人化治療方法，他們對生物樣本庫基礎設施的依賴預計將顯著增加。預計這一趨勢將在預測期內推動持續的市場需求。

由於迫切需要生物檢體來支持疫苗研發、診斷創新和公共衛生研究，COVID-19 疫情顯著加速了美國對生物樣本庫的需求。生物樣本庫在收集、保存和分發 COVID-19 相關樣本方面發揮了關鍵作用，使我們能夠快速應對新出現的變異株，並增進我們對疾病進展的理解。生物樣本庫的貢獻有助於加速臨床試驗，支持監管核准，並在疫情期間推動治療和預防策略。

然而，美國市場受到有關資料隱私、知情同意和樣本可追溯性的嚴格監管要求以及高昂的基礎設施和維護成本的限制——這些挑戰可能會限制可擴充性，尤其是對於較小的機構和新興企業。

美國生物樣本庫市場報告重點

  • 預計服務領域將在2024年佔據最大的市場佔有率，並在預測期內以最快的複合年成長率成長，這得益於端到端樣品管理、處理和存儲解決方案的需求不斷成長，尤其是在製藥和研究領域。預計產品領域將在預測期內實現顯著成長。
  • 人體組織領域預計將在2024年佔據市場佔有率達到36.91%，這得益於其在疾病研究、生物標記發現和藥物開發（尤其是在腫瘤學和再生醫學領域）中的關鍵作用。然而，預計幹細胞的成長速度最快，預測期內複合年成長率將達到7.40%。
  • 預計到2024年，實體生物樣本庫將佔據最大的市場佔有率，這得益於其完善的基礎設施、在受控條件下儲存多樣化生物檢體的能力，以及在臨床試驗和轉化研究中的廣泛應用。然而，虛擬生物樣本庫預計在預測期內將以最快的複合年成長率成長。
  • 預計到2024年，治療領域將在應用領域佔據最大佔有率，並在預測期內實現最快的複合年成長率。這得歸功於生物庫樣本在標靶治療、再生療法和個人化醫療方法開發中日益普及的現象。然而，臨床診斷領域預計在預測期內也將顯著成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章市場變數、趨勢和範圍

  • 市場展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國生物樣本庫市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章美國生物庫市場：產品與服務估計與趨勢分析

  • 產品/服務細分儀表板
  • 美國生物樣本庫市場產品與服務變化分析
  • 美國生物樣本庫市場規模及趨勢分析（依產品/服務，2018-2030）
  • 產品
    • 2018-2030年產品市場
    • 生物銀行設備
    • 生物銀行耗材
    • 實驗室資訊管理系統
  • 服務
    • 服務市場，2018-2030
    • 生物銀行庫
    • 實驗室處理
    • 資格/檢驗
    • 低溫運輸物流
    • 其他服務

第5章美國生物樣本庫市場：生物檢體估計與趨勢分析

  • 生物檢體細分儀表板
  • 美國生物樣本庫市場生物檢體變異分析
  • 美國生物檢體樣本庫市場規模與趨勢分析（2018-2030年）
  • 人體組織
    • 人體組織市場，2018-2030
  • 器官
    • 器官市場，2018-2030
  • 幹細胞
    • 幹細胞市場，2018-2030
    • 成體幹細胞
    • 胚胎幹細胞
    • IPS細胞
    • 其他幹細胞
  • 其他生物標本
    • 其他生物檢體市場，2018-2030

第6章美國生物樣本庫市場：類型評估與趨勢分析

  • 類型細分儀表板
  • 美國生物樣本庫市場波動分析
  • 美國生物樣本庫市場規模與趨勢分析（2018-2030）
  • 物理/物理生物庫
    • 實體生物樣本庫市場，2018-2030
    • 組織生物庫
    • 基於人群的生物樣本庫
    • 遺傳學（DNA/RNA）
    • 基於疾病的生物庫
  • 虛擬生物庫
    • 虛擬生物庫市場，2018-2030

第7章：美國生物樣本庫市場：應用評估與趨勢分析

  • 應用程式細分儀表板
  • 美國生物樣本庫市場使用趨勢分析
  • 美國生物樣本庫市場規模及趨勢分析（按應用，2018-2030）
  • 治療
    • 治療藥物市場，2018-2030
  • 藥物研發與臨床研究
    • 2018-2030年藥物研發與臨床研究市場
  • 臨床診斷
    • 臨床診斷市場，2018-2030
  • 其他用途
    • 其他應用市場，2018-2030年

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • QIAGEN
    • Hamilton Company
    • Tecan Trading Ag
    • ViaCord（Revitty）
    • Cryo-Cell
    • BioCision, Llc.
    • Icbiomedical
    • Charles River Laboratories
    • Azenta US Inc.
    • Stemcell Technologies
    • Biovault Family
    • LabVantage Solutions Inc.
    • Precision Cellular Storage Ltd.
Product Code: GVR-4-68040-585-1

U.S. Biobanks Market Growth & Trends:

The U.S. biobanks market size is anticipated to reach USD 24.48 billion by 2030 and is projected to grow at a CAGR of 6.26% from 2025 to 2030, according to a new report by Grand View Research, Inc. This growth is attributed to rising demand for quality biospecimens in drug development, personalized medicine, and clinical research. Advancements in biobanking technologies, growing investments from pharmaceutical and biotech firms, and expanding applications in genomics and regenerative medicine further drive market expansion.

The increasing emphasis on precision medicine significantly boosts the demand for quality, well-annotated biospecimens across the U.S. healthcare and research landscape. These samples are essential for supporting critical activities such as biomarker discovery, patient stratification, and the development of targeted therapies. Biobanks play a pivotal role in this process by offering reliable access to diverse and clinically relevant biological materials, vital for translational research and drug development. As pharmaceutical companies, research institutions, and diagnostics firms prioritize personalized treatment approaches, the reliance on biobank infrastructure is expected to grow substantially. This trend is poised to drive sustained market demand over the forecast period.

The COVID-19 pandemic significantly accelerated the demand for biobanks in the U.S., driven by the urgent need for biological specimens to support vaccine development, diagnostic innovation, and public health research. Biobanks played a vital role in collecting, preserving, and distributing COVID-19-related samples, enabling faster response to emerging variants and enhancing understanding of disease progression. Their contribution helped accelerate clinical trials, support regulatory approvals, and advance therapeutic and preventive strategies during the pandemic.

However, the U.S. market faces constraints due to high infrastructure and maintenance costs, along with stringent regulatory requirements related to data privacy, informed consent, and sample traceability. These challenges can limit scalability, particularly for smaller institutions and emerging players.

U.S. Biobanks Market Report Highlights:

  • The services held the largest market share in 2024 and are anticipated to grow at the fastest CAGR over the forecast period. This is attributed to increasing demand for end-to-end sample management, processing, and storage solutions, especially from the pharma and research sectors. The product segment is expected to grow significantly over the forecast period.
  • The human tissues segment dominated with a market share of 36.91% in 2024. This is driven by their critical role in disease research, biomarker discovery, and drug development, particularly in oncology and regenerative medicine. However, stem cells are anticipated to grow at the fastest CAGR of 7.40% over the forecast period.
  • The physical/real biobank held the largest market share in 2024. This is driven by their established infrastructure, ability to store diverse biospecimens under controlled conditions, and widespread use in clinical trials and translational research. However, virtual biobank types are anticipated to grow at the fastest CAGR over the forecast period.
  • The therapeutics segment dominated the application segment with the largest share in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by the increasing use of biobanked samples in developing targeted treatments, regenerative therapies, and personalized medicine approaches. However, clinical diagnostics are expected to grow significantly over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Products & Services Segment
    • 1.2.2. Biospecimen Segment
    • 1.2.3. Type Segment
    • 1.2.4. Application Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increased focus on precision medicine and genetic testing
      • 3.2.1.2. Changes in biobanking operations
      • 3.2.1.3. Increase in the number of clinical trials
      • 3.2.1.4. Growing biobanking industry and research collaborations
      • 3.2.1.5. Technology advancement and automation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Challenges in sharing biobanking data & limited access to biospecimens
      • 3.2.2.2. Sustainability challenges for biobanks
      • 3.2.2.3. Challenges associated with biobanking specimen management
  • 3.3. U.S. Biobanks Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Biobanks Market: Products & Services, Trend Analysis

  • 4.1. Products & Services Segment Dashboard
  • 4.2. U.S. Biobanks Market Products & Services Movement Analysis
  • 4.3. U.S. Biobanks Market Size & Trend Analysis, by Products & Services, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Products Market, 2018 - 2030 (USD Million)
    • 4.4.2. Biobanking Equipment
      • 4.4.2.1. Biobanking Equipment Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. Temperature Control Systems
        • 4.4.2.2.1. Temperature Control Systems Market, 2018 - 2030 (USD Million)
        • 4.4.2.2.2. Freezers & Refrigerators
          • 4.4.2.2.2.1. Freezers & Refrigerators Market, 2018 - 2030 (USD Million)
        • 4.4.2.2.3. Cryogenic Storage Systems
          • 4.4.2.2.3.1. Cryogenic Storage Systems Market, 2018 - 2030 (USD Million)
        • 4.4.2.2.4. Thawing Equipment
          • 4.4.2.2.4.1. Thawing Equipment Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. Incubators & Centrifuges
        • 4.4.2.3.1. Incubators & Centrifuges Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Alarms & Monitoring Systems
        • 4.4.2.4.1. Alarms & Monitoring Systems Market, 2018 - 2030 (USD Million)
      • 4.4.2.5. Accessories & Other Equipment
        • 4.4.2.5.1. Accessories & Other Equipment Market, 2018 - 2030 (USD Million)
    • 4.4.3. Biobanking Consumables
      • 4.4.3.1. Biobanking Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.4. Laboratory Information Management Systems
      • 4.4.4.1. Laboratory Information Management Systems Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market, 2018 - 2030 (USD Million)
    • 4.5.2. Biobanking & Repository
      • 4.5.2.1. Biobanking & Repository Market, 2018 - 2030 (USD Million)
    • 4.5.3. Lab processing
      • 4.5.3.1. Lab processing Market, 2018 - 2030 (USD Million)
    • 4.5.4. Qualification/ Validation
      • 4.5.4.1. Qualification/ Validation Market, 2018 - 2030 (USD Million)
    • 4.5.5. Cold Chain Logistics
      • 4.5.5.1. Cold Chain Logistics Market, 2018 - 2030 (USD Million)
    • 4.5.6. Other Services
      • 4.5.6.1. Other Services Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Biobanks Market: Biospecimen Estimates & Trend Analysis

  • 5.1. Biospecimen Segment Dashboard
  • 5.2. U.S. Biobanks Market Biospecimen Movement Analysis
  • 5.3. U.S. Biobanks Market Size & Trend Analysis, by Biospecimen, 2018 to 2030 (USD Million)
  • 5.4. Human Tissues
    • 5.4.1. Human Tissues Market, 2018 - 2030 (USD Million)
  • 5.5. Organs
    • 5.5.1. Organs Market, 2018 - 2030 (USD Million)
  • 5.6. Stem Cells
    • 5.6.1. Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.2. Adult Stem Cells
      • 5.6.2.1. Adult Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.3. Embryonic Stem Cells
      • 5.6.3.1. Embryonic Stem Cells Market, 2018 - 2030 (USD Million)
    • 5.6.4. IPS Cells
      • 5.6.4.1. IPS Cells Market, 2018 - 2030 (USD Million)
    • 5.6.5. Other Stem Cells
      • 5.6.5.1. Other Stem Cells Market, 2018 - 2030 (USD Million)
  • 5.7. Other Biospecimens
    • 5.7.1. Other Biospecimens Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Biobanks Market: Type Estimates & Trend Analysis

  • 6.1. Type Segment Dashboard
  • 6.2. U.S. Biobanks Market Type Movement Analysis
  • 6.3. U.S. Biobanks Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 6.4. Physical/Real Biobanks
    • 6.4.1. Physical/Real Biobanks Market, 2018 - 2030 (USD Million)
    • 6.4.2. Tissue Biobanks
      • 6.4.2.1. Tissue Biobanks Market, 2018 - 2030 (USD Million)
    • 6.4.3. Population Based Biobanks
      • 6.4.3.1. Population Based Biobanks Market, 2018 - 2030 (USD Million)
    • 6.4.4. Genetic (DNA/RNA)
      • 6.4.4.1. Genetic (DNA/RNA) Market, 2018 - 2030 (USD Million)
    • 6.4.5. Disease Based Biobanks
      • 6.4.5.1. Disease Based Biobanks Market, 2018 - 2030 (USD Million)
  • 6.5. Virtual Biobanks
    • 6.5.1. Virtual Biobanks Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Biobanks Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. U.S. Biobanks Market Application Movement Analysis
  • 7.3. U.S. Biobanks Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Therapeutics
    • 7.4.1. Therapeutics Market, 2018 - 2030 (USD Million)
  • 7.5. Drug Discovery & Clinical Research
    • 7.5.1. Drug Discovery & Clinical Research Market, 2018 - 2030 (USD Million)
  • 7.6. Clinical Diagnostics
    • 7.6.1. Clinical Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.7. Other Application
    • 7.7.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. Thermo Fisher Scientific, Inc.
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Merck KGaA
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. QIAGEN
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Hamilton Company
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Tecan Trading Ag
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. ViaCord (Revitty)
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Cryo-Cell
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. BioCision, Llc.
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Icbiomedical
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Charles River Laboratories
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Azenta US Inc.
      • 8.3.11.1. Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. Stemcell Technologies
      • 8.3.12.1. Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Biovault Family
      • 8.3.13.1. Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. LabVantage Solutions Inc.
      • 8.3.14.1. Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Product Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. Precision Cellular Storage Ltd.
      • 8.3.15.1. Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Product Benchmarking
      • 8.3.15.4. Strategic Initiatives

List of Tables

  • Table 1. U.S. biobanks market estimates & forecasts
  • Table 2. U.S. biobanks market estimates & forecasts, by products & services, 2018 - 2030 (USD Million)
  • Table 3. U.S. biobanks market estimates & forecasts, by biospecimen, 2018 - 2030 (USD Million)
  • Table 4. U.S. biobanks market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 5. U.S. biobanks market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 Participant categorization
  • Fig. 14 U.S. biobanks market: Products & services outlook key takeaways
  • Fig. 15 U.S. biobanks market: Products & services movement analysis
  • Fig. 16 Products market, 2018 - 2030 (USD Million)
  • Fig. 17 Biobanking equipment market, 2018 - 2030 (USD Million)
  • Fig. 18 Temperature control systems market, 2018 - 2030 (USD Million)
  • Fig. 19 Freezers & refrigerators market, 2018 - 2030 (USD Million)
  • Fig. 20 Cryogenic storage systems market, 2018 - 2030 (USD Million)
  • Fig. 21 Thawing equipment market, 2018 - 2030 (USD Million)
  • Fig. 22 Incubators & centrifuges market, 2018 - 2030 (USD Million)
  • Fig. 23 Alarms & monitoring systems market, 2018 - 2030 (USD Million)
  • Fig. 24 Accessories & other equipment market, 2018 - 2030 (USD Million)
  • Fig. 25 Biobanking consumables market, 2018 - 2030 (USD Million)
  • Fig. 26 Laboratory information management systems market, 2018 - 2030 (USD Million)
  • Fig. 27 Services market, 2018 - 2030 (USD Million)
  • Fig. 28 Biobanking & repository market, 2018 - 2030 (USD Million)
  • Fig. 29 Lab processing market, 2018 - 2030 (USD Million)
  • Fig. 30 Qualification/validation market, 2018 - 2030 (USD Million)
  • Fig. 31 Cold chain logistics market, 2018 - 2030 (USD Million)
  • Fig. 32 Other services market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. biobanks market: Biospecimen outlook key takeaways
  • Fig. 34 U.S. biobanks market: Biospecimen movement analysis
  • Fig. 35 Human tissues market, 2018 - 2030 (USD Million)
  • Fig. 36 Organs market, 2018 - 2030 (USD Million)
  • Fig. 37 Stem cells tissues market, 2018 - 2030 (USD Million)
  • Fig. 38 Adult stem cells market, 2018 - 2030 (USD Million)
  • Fig. 39 Embryonic stem cells market, 2018 - 2030 (USD Million)
  • Fig. 40 IPS cells market, 2018 - 2030 (USD Million)
  • Fig. 41 Other stem cells market, 2018 - 2030 (USD Million)
  • Fig. 42 Other biospecimens market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. biobanks market: Type outlook key takeaways
  • Fig. 44 U.S. biobanks market: Type movement analysis
  • Fig. 45 Physical/real biobanks market, 2018 - 2030 (USD Million)
  • Fig. 46 Tissue biobanks market, 2018 - 2030 (USD Million)
  • Fig. 47 Population-based biobanks market, 2018 - 2030 (USD Million)
  • Fig. 48 Genetic (DNA/RNA) market, 2018 - 2030 (USD Million)
  • Fig. 49 Disease-based biobanks market, 2018 - 2030 (USD Million)
  • Fig. 50 Virtual biobanks market, 2018 - 2030 (USD Million)
  • Fig. 51 U.S. biobanks market: Application outlook key takeaways
  • Fig. 52 U.S. biobanks market: Application movement analysis
  • Fig. 53 Therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Drug discovery & clinical research market, 2018 - 2030 (USD Million)
  • Fig. 55 Clinical diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Other application market, 2018 - 2030 (USD Million)
  • Fig. 57 U.S. biobanks market, 2018 - 2030 (USD Million)
  • Fig. 58 Key companies profiled